{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:10:54Z","timestamp":1786975854912,"version":"build-2736575974"},"update-to":[{"DOI":"10.1002\/14651858.cd013066","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,8,29]],"date-time":"2020-08-29T00:00:00Z","timestamp":1598659200000}}],"reference-count":126,"publisher":"Wiley","issue":"12","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd013066.pub2","type":"journal-article","created":{"date-parts":[[2020,8,29]],"date-time":"2020-08-29T08:37:07Z","timestamp":1598690227000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Citicoline for treating people with acute ischemic stroke"],"prefix":"10.1002","volume":"2020","author":[{"given":"Arturo J","family":"Mart\u00ed-Carvajal","sequence":"additional","affiliation":[{"name":"Facultad de Ciencias de la Salud Eugenio Espejo; Universidad UTE (Cochrane Ecuador); Quito Ecuador"},{"name":"School of Medicine; Universidad Francisco de Vitoria (Cochrane Madrid); Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Valli","sequence":"additional","affiliation":[{"name":"Iberoamerican Cochrane Centre; Biomedical Research Institute Sant Pau (IIB Sant Pau); Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina Elena","family":"Mart\u00ed-Amarista","sequence":"additional","affiliation":[{"name":"Department of Family Medicine; Northwell Health Southside Hospital; Bay Shore New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Sol\u00e0","sequence":"additional","affiliation":[{"name":"Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau (IIB Sant Pau); CIBER Epidemiolog\u00eda y Salud P\u00fablica (CIBERESP); Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Mart\u00ed-F\u00e0bregas","sequence":"additional","affiliation":[{"name":"Unitat de Malalties Vasculars Cerebrals - Stroke Unit, Servei De Neurologia - Department of Neurology; Hospital de la Santa Creu i Sant Pau; Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Bonfill Cosp","sequence":"additional","affiliation":[{"name":"Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau (IIB Sant Pau), Universitat Aut\u00f2noma de Barcelona; CIBER Epidemiolog\u00eda y Salud P\u00fablica (CIBERESP); Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,8,29]]},"reference":[{"issue":"2","key":"10.1002\/14651858.CD013066.pub2-BIB0001|cit1","first-page":"127","article-title":"Effectiveness and tolerability of citicoline in acute ischemic stroke, randomized, double-blind study compared with placebo","volume":"26","author":"Alvairez","year":"2007","journal-title":"Archivos Venezolanos de Farmacolog\u00eda y Terap\u00e9utica"},{"issue":"3","key":"10.1002\/14651858.CD013066.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1212\/WNL.49.3.671","article-title":"A randomized dose-response trial of citicoline in acute ischemic stroke patients","volume":"49","author":"Clark","year":"1997","journal-title":"Neurology"},{"issue":"12","key":"10.1002\/14651858.CD013066.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1161\/01.STR.30.12.2592","article-title":"A randomized efficacy trial of citicoline in patients with acute ischemic stroke","volume":"30","author":"Clark","year":"1999","journal-title":"Stroke"},{"issue":"9","key":"10.1002\/14651858.CD013066.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1212\/WNL.57.9.1595","article-title":"A phase III randomized efficacy trial of 2000 mg citicoline in acute ischemic stroke patients","volume":"57","author":"Clark","year":"2001","journal-title":"Neurology"},{"issue":"5","key":"10.1002\/14651858.CD013066.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"697","DOI":"10.4103\/0028-3886.166538","article-title":"The effect of citicoline on stroke: a comparative study from the Eastern part of India","volume":"63","author":"Ghosh","year":"2015","journal-title":"Neurology India"},{"key":"10.1002\/14651858.CD013066.pub2-BIB0006|cit6","unstructured":"Guillen F Buendia C Herrera J CDP-choline in the treatment of acute ischaemic stroke Journal of Neurology 1995 242 Suppl 2 S76"},{"issue":"9839","key":"10.1002\/14651858.CD013066.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0140-6736(12)60813-7","article-title":"Citicoline in the treatment of acute ischaemic stroke: an international, randomised, multicentre, placebo-controlled study (ICTUS trial)","volume":"380","author":"D\u00e1valos","year":"2012","journal-title":"Lancet"},{"issue":"6","key":"10.1002\/14651858.CD013066.pub2-BIB0008|cit8","first-page":"480","article-title":"The effects of citicoline on cerebrovascular hemodynamic status in ischemic stroke patients","volume":"24","author":"Seifaddini","year":"2017","journal-title":"Journal of Kerman University of Medical Sciences"},{"issue":"2","key":"10.1002\/14651858.CD013066.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1161\/01.STR.19.2.211","article-title":"Treatment of acute cerebral infarction with a choline precursor in a multicenter double-blind placebo-controlled study","volume":"19","author":"Tazaki","year":"1988","journal-title":"Stroke"},{"issue":"5","key":"10.1002\/14651858.CD013066.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/1531-8249(200011)48:5<713::AID-ANA4>3.0.CO;2-#","article-title":"Effect of citicoline on ischemic lesions as measured by diffusion-weighted magnetic resonance imaging","volume":"48","author":"Warach","year":"2000","journal-title":"Annals of Neurology"},{"key":"10.1002\/14651858.CD013066.pub2-BIB0011|cit11","unstructured":"Gallois P Comparison of the results with corticotrophin and citicoline in the initial stage of cerebral infarction Gazette Medicale 1987 94 4 82 5"},{"key":"10.1002\/14651858.CD013066.pub2-BIB0012|cit12","unstructured":"Djoenaidi W Susilo H Hakim AA Batubara A Koentioro EA A double-blind controlled trial of cytidine-diphosphate-choline (CDPcholine) on thrombotic stroke patients 12th World Congress of Neurology, Kyoto (Japan), September (Abstract 869) 1981"},{"key":"10.1002\/14651858.CD013066.pub2-BIB0013|cit13","unstructured":"Goel D ECCT-HIS. Edaravone-Citicoline comparative trial in head injury and stroke Available at www.strokecenter.org\/trials\/clinicalstudies\/edaravone-citicoline-comparative-trial-in-head-injury-and-stroke"},{"issue":"11","key":"10.1002\/14651858.CD013066.pub2-BIB0014|cit14","first-page":"36","article-title":"Edaravone - citicoline comparative study in acute ischemic stroke (ECCS-AIS)","volume":"60","author":"Mittal","year":"2012","journal-title":"Journal of the Association of Physicians of India"},{"key":"10.1002\/14651858.CD013066.pub2-BIB0015|cit15","unstructured":"Garcia Pastor A Diaz Otero F Gil Nunez AC Villanueva Osorio JA Tolerability and efficacy of the combination of piracetam and citicoline in acute ischemic stroke. A randomized comparative open study Stroke 2004 35 6 e286"},{"key":"10.1002\/14651858.CD013066.pub2-BIB0016|cit16","unstructured":"Goas JY Bastard J Missoum A Results after 90 days of stroke treatment with CDP-choline concerning a double-blind test International Symposium. Brain Suffering and Precursor of Phospholipids. Paris 1980, January 18;109-21. 1980 123 8"},{"key":"10.1002\/14651858.CD013066.pub2-BIB0017|cit17","unstructured":"Melnikova EV Shmonin AA Kulagin PA Stukova LN Mischenko KA Neuroprotection effectiveness depends on the size and location of the ischemic stroke focus Cerebrovascular Diseases 2011 31 Suppl 2 132"},{"issue":"S3","key":"10.1002\/14651858.CD013066.pub2-BIB0018|cit18","first-page":"412","article-title":"Patients treated with citicoline in acute phase of ischemic stroke report better quality of life","volume":"16","author":"Panteleienko","year":"2009","journal-title":"European Journal of Neurology"},{"issue":"2","key":"10.1002\/14651858.CD013066.pub2-BIB0019|cit19","doi-asserted-by":"publisher","first-page":"262","DOI":"10.31838\/ijpr\/2019.11.02.045","article-title":"Effect of citicoline on cerebral hemodynamics and vasoreactivity using transcranial doppler in acute ischemic stroke patients: clinical trial","volume":"11","author":"Hassan","year":"2019","journal-title":"International Journal of Pharmaceutical Research"},{"key":"10.1002\/14651858.CD013066.pub2-BIB0020|cit20","unstructured":"Agarwal A Vishnu VY Bhatia R Goyal V Singh MB Joseph L [Abstract 431] Citicoline in acute ischemic stroke - a randomized control trial International Journal of Stroke 2018 13 2S 104"},{"key":"10.1002\/14651858.CD013066.pub2-BIB0021|cit21","unstructured":""},{"issue":"1","key":"10.1002\/14651858.CD013066.pub2-BIB0022|cit22","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.MR000039.pub2","article-title":"Eliciting adverse effects data from participants in clinical trials","author":"Allen","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD013066.pub2-BIB0023|cit23","doi-asserted-by":"crossref","unstructured":"Altman DG Deeks JJ Sackett DL Odds ratios should be avoided when events are common BMJ 1998 317 7168 1318 9804732","DOI":"10.1136\/bmj.317.7168.1318"},{"issue":"6","key":"10.1002\/14651858.CD013066.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1161\/01.STR.12.6.723","article-title":"Thresholds in cerebral ischemia - the ischemic penumbra","volume":"12","author":"Astrup","year":"1981","journal-title":"Stroke"},{"issue":"4","key":"10.1002\/14651858.CD013066.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3171\/jns.1982.56.4.0482","article-title":"Energy-requiring cell functions in the ischemic brain. Their critical supply and possible inhibition in protective therapy","volume":"56","author":"Astrup","year":"1982","journal-title":"Journal of Neurosurgery"},{"issue":"7454","key":"10.1002\/14651858.CD013066.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"GRADE Working Group. Grading quality of evidence and strength of recommendations","volume":"328","author":"Atkins","year":"2004","journal-title":"BMJ"},{"issue":"3","key":"10.1002\/14651858.CD013066.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.3390\/brainsci3031395","article-title":"The role of citicoline in neuroprotection and neurorepair in ischemic stroke","volume":"3","author":"\u00c1varez-Sab\u00edn","year":"2013","journal-title":"Brain Sciences"},{"issue":"19","key":"10.1002\/14651858.CD013066.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1001\/jama.279.19.1566","article-title":"Why review articles on the health effects of passive smoking reach different conclusions","volume":"279","author":"Barnes","year":"1998","journal-title":"JAMA"},{"issue":"6","key":"10.1002\/14651858.CD013066.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1747-4949.2011.00614.x","article-title":"Calculation of numbers-needed-to-treat in parallel group trials assessing ordinal outcomes: case examples from acute stroke and stroke prevention","volume":"6","author":"Bath","year":"2011","journal-title":"International Journal of Stroke"},{"issue":"4","key":"10.1002\/14651858.CD013066.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1161\/STROKEAHA.111.641456","article-title":"Statistical analysis of the primary outcome in acute stroke trials","volume":"43","author":"Bath","year":"2012","journal-title":"Stroke"},{"issue":"7247","key":"10.1002\/14651858.CD013066.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1136\/bmj.320.7247.1468","article-title":"Statistics notes. The odds ratio","volume":"320","author":"Bland","year":"2000","journal-title":"BMJ"},{"issue":"8","key":"10.1002\/14651858.CD013066.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.jclinepi.2007.10.007","article-title":"Trial Sequential Analysis reveals insufficient information size and potentially false positive results in many meta-analyses","volume":"61","author":"Brok","year":"2008","journal-title":"Journal of Clinical Epidemiology"},{"issue":"1","key":"10.1002\/14651858.CD013066.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/ije\/dyn188","article-title":"Apparently conclusive meta-analyses may be inconclusive: Trial Sequential Analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses","volume":"38","author":"Brok","year":"2009","journal-title":"International Journal of Epidemiology"},{"key":"10.1002\/14651858.CD013066.pub2-BIB0034|cit34","unstructured":"Carroll DG Functional evaluation: the Barthel index www.strokecenter.org\/wp-content\/uploads\/2011\/08\/barthel_reprint.pdf"},{"issue":"4","key":"10.1002\/14651858.CD013066.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.emc.2017.07.007","article-title":"Ischemic stroke: advances in diagnosis and management","volume":"35","author":"Cassella","year":"2017","journal-title":"Emergency Medicine Clinics of North America"},{"issue":"4","key":"10.1002\/14651858.CD013066.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1136\/eb-2014-101967","article-title":"A hands-on practical tutorial on performing meta-analysis with Stata","volume":"17","author":"Chaimani","year":"2014","journal-title":"Evidence-based Mental Health"},{"key":"10.1002\/14651858.CD013066.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"a2299","DOI":"10.1136\/bmj.a2299","article-title":"Discrepancies in sample size calculations and data analyses reported in randomised trials: comparison of publications with protocols","volume":"337","author":"Chan","year":"2008","journal-title":"BMJ"},{"issue":"6","key":"10.1002\/14651858.CD013066.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"522\u201330","DOI":"10.1016\/j.apsb.2016.06.013","article-title":"The fate of medications evaluated for ischemic stroke pharmacotherapy over the period 1995\u20132015","volume":"6","author":"Chen","year":"2016","journal-title":"Acta Pharmaceutica Sinica B"},{"issue":"5","key":"10.1002\/14651858.CD013066.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1517\/14656560902765652","article-title":"Efficacy of citicoline as an acute stroke treatment","volume":"10","author":"Clark","year":"2009","journal-title":"Expert Opinion on Pharmacotherapy"},{"key":"10.1002\/14651858.CD013066.pub2-BIB0040|cit40","unstructured":"Consolidated Standards of Reporting Trials www.consort-statement.org\/"},{"key":"10.1002\/14651858.CD013066.pub2-BIB0041|cit41","unstructured":"Copenhagen Trial Unit TSA - Trial Sequential Analysis ctu.dk\/tsa\/"},{"issue":"12","key":"10.1002\/14651858.CD013066.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1161\/01.STR.0000038691.03334.71","article-title":"Oral citicoline in acute ischemic stroke: an individual patient data pooling analysis of clinical trials","volume":"33","author":"D\u00e1valos","year":"2002","journal-title":"Stroke"},{"issue":"7136","key":"10.1002\/14651858.CD013066.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1136\/bmj.316.7136.989","article-title":"When can odds ratios mislead?","volume":"316","author":"Davies","year":"1998","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD013066.pub2-BIB0044|cit44","unstructured":"Deeks JJ Higgins JPT Altman DG (editors) on behalf of the Cochrane Statistical Methods Group Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), Cochrane, 2017.The Cochrane Collaboration, 2017 Available from www.training.cochrane.org\/handbook"},{"issue":"16","key":"10.1002\/14651858.CD013066.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1002\/sim.6909","article-title":"Type-II generalized family-wise error rate formulas with application to sample size determination","volume":"35","author":"Delorme","year":"2016","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD013066.pub2-BIB0046|cit46","volume-title":"Understanding Psychology as a Science: An Introduction to Scientific and Statistical Inference","author":"Dienes","year":"2008"},{"key":"10.1002\/14651858.CD013066.pub2-BIB0047|cit47","doi-asserted-by":"publisher","first-page":"781","DOI":"10.3389\/fpsyg.2014.00781","article-title":"Using Bayes to get the most out of non-significant results","volume":"5","author":"Dienes","year":"2014","journal-title":"Frontiers in Psychology"},{"issue":"1","key":"10.1002\/14651858.CD013066.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3758\/s13423-017-1266-z","article-title":"Four reasons to prefer Bayesian analyses over significance testing","volume":"25","author":"Dienes","year":"2018","journal-title":"Psychonomic Bulletin and Review"},{"key":"10.1002\/14651858.CD013066.pub2-BIB0049|cit49","unstructured":"www.fda.gov\/inspections-compliance-enforcement-and-criminal-investigations\/warning-letters\/pure-nootropics-llc-565425-02052019 2019"},{"issue":"5","key":"10.1002\/14651858.CD013066.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.jclinepi.2010.09.016","article-title":"Ratio of means for analyzing continuous outcomes in meta-analysis performed as well as mean difference methods","volume":"64","author":"Friedrich","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD013066.pub2-BIB0051|cit51","doi-asserted-by":"crossref","unstructured":"Furukawa TA From effect size into number needed to treat Lancet 1999 353 9165 1680 10335798","DOI":"10.1016\/S0140-6736(99)01163-0"},{"issue":"4","key":"10.1002\/14651858.CD013066.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"e19070","DOI":"10.1371\/journal.pone.0019070","article-title":"How to obtain NNT from Cohen's d: comparison of two methods","volume":"6","author":"Furukawa","year":"2011","journal-title":"PLoS One"},{"issue":"6","key":"10.1002\/14651858.CD013066.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.jclinepi.2004.09.013","article-title":"Uncertainty method improved on best-worst case analysis in a binary meta-analysis","volume":"58","author":"Gamble","year":"2005","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD013066.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.7326\/0003-4819-130-12-199906150-00019","article-title":"Toward evidence-based medical statistics. 2: The Bayes factor","volume":"130","author":"Goodman","year":"1999","journal-title":"Annals of Internal Medicine"},{"issue":"4","key":"10.1002\/14651858.CD013066.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1191\/1740774505cn098oa","article-title":"Introduction to Bayesian methods I: measuring the strength of evidence","volume":"2","author":"Goodman","year":"2005","journal-title":"Clinical Trials"},{"key":"10.1002\/14651858.CD013066.pub2-BIB0056|cit56","unstructured":"GRADEpro GDT McMaster University (developed by Evidence Prime) 2015"},{"issue":"3","key":"10.1002\/14651858.CD013066.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s40263-014-0144-8","article-title":"Neuroprotective properties of citicoline: facts, doubts and unresolved issues","volume":"28","author":"Grieb","year":"2014","journal-title":"CNS Drugs"},{"key":"10.1002\/14651858.CD013066.pub2-BIB0058|cit58","doi-asserted-by":"crossref","unstructured":"Hankey GJ Stroke Lancet 2017 389 10069 641 54 27637676","DOI":"10.1016\/S0140-6736(16)30962-X"},{"key":"10.1002\/14651858.CD013066.pub2-BIB0059|cit59","first-page":"201","article-title":"Assessment scales in stroke: clinimetric and clinical considerations","volume":"8","author":"Harrison","year":"2013","journal-title":"Clinical Interventions in Aging"},{"issue":"7414","key":"10.1002\/14651858.CD013066.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD013066.pub2-BIB0061|cit61","unstructured":"Higgins JP Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD013066.pub2-BIB0062|cit62","unstructured":"Higgins JP Deeks JJ Chapter 7: Selecting studies and collecting data. In: Higgins JP, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD013066.pub2-BIB0063|cit63","unstructured":"Higgins JP Altman DG Sterne JA Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD013066.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/9781119536604.ch6","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins","year":"2019"},{"key":"10.1002\/14651858.CD013066.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3389\/fneur.2015.00085","article-title":"Editorial: the ischemic penumbra: still the target for stroke therapies?","volume":"6","author":"Hillis","year":"2015","journal-title":"Frontiers in Neurology"},{"key":"10.1002\/14651858.CD013066.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"g1687","DOI":"10.1136\/bmj.g1687","article-title":"Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide","volume":"348","author":"Hoffmann","year":"2014","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD013066.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"j2998","DOI":"10.1136\/bmj.j2998","article-title":"Enhancing the usability of systematic reviews by improving the consideration and description of interventions","volume":"357","author":"Hoffmann","year":"2017","journal-title":"BMJ"},{"issue":"7211","key":"10.1002\/14651858.CD013066.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1136\/bmj.319.7211.670","article-title":"What is meant by intention to treat analysis? Survey of published randomised controlled trials","volume":"319","author":"Hollis","year":"1999","journal-title":"BMJ (Clinical Research Ed)"},{"issue":"6","key":"10.1002\/14651858.CD013066.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1213\/ANE.0000000000000892","article-title":"Systematic reviews of anesthesiologic interventions reported as statistically significant: problems with power, precision, and type 1 error protection","volume":"121","author":"Imberger","year":"2015","journal-title":"Anesthesia and Analgesia"},{"issue":"8","key":"10.1002\/14651858.CD013066.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"e011890","DOI":"10.1136\/bmjopen-2016-011890","article-title":"False-positive findings in Cochrane meta-analyses with and without application of Trial Sequential Analysis: an empirical review","volume":"6","author":"Imberger","year":"2016","journal-title":"BMJ Open"},{"issue":"7","key":"10.1002\/14651858.CD013066.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"e010247","DOI":"10.1136\/bmjopen-2015-010247","article-title":"Plea for routinely presenting prediction intervals in meta-analysis","volume":"6","author":"IntHout","year":"2016","journal-title":"BMJ Open"},{"key":"10.1002\/14651858.CD013066.pub2-BIB0072|cit72","doi-asserted-by":"crossref","unstructured":"Ioannidis JP Adverse events in randomized trials: neglected, restricted, distorted, and silenced Archives of Internal Medicine 2009 169 19 1737 9 19858427","DOI":"10.1001\/archinternmed.2009.313"},{"issue":"3-4","key":"10.1002\/14651858.CD013066.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/jrsm.19","article-title":"Meta-research: The art of getting it wrong","volume":"1","author":"Ioannidis","year":"2010","journal-title":"Research synthesis methods"},{"issue":"10","key":"10.1002\/14651858.CD013066.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"e1001747","DOI":"10.1371\/journal.pmed.1001747","article-title":"How to make more published research true","volume":"11","author":"Ioannidis","year":"2014","journal-title":"PLoS Medicine"},{"key":"10.1002\/14651858.CD013066.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/1471-2288-14-120","article-title":"Thresholds for statistical and clinical significance in systematic reviews with meta-analytic methods","volume":"14","author":"Jakobsen","year":"2014","journal-title":"BMC Medical Research Methodology"},{"issue":"1","key":"10.1002\/14651858.CD013066.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1503\/cmaj.150430","article-title":"Do clinicians understand the size of treatment effects? A randomized survey across 8 countries","volume":"188","author":"Johnston","year":"2016","journal-title":"Canadian Medical Association Journal"},{"issue":"3","key":"10.1002\/14651858.CD013066.pub2-BIB0077|cit77","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1093\/biomet\/70.3.659","article-title":"Discrete sequential boundaries for clinical trials","volume":"70","author":"Lan","year":"1983","journal-title":"Biometrika"},{"issue":"26","key":"10.1002\/14651858.CD013066.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1056\/NEJM198806303182605","article-title":"An assessment of clinically useful measures of the consequences of treatment","volume":"318","author":"Laupacis","year":"1988","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD013066.pub2-BIB0079|cit79","first-page":"e263 (Abstract","article-title":"Choline precursors in acute and subacute ischemic and hemorrhagic stroke: an updated meta-analysis of randomized controlled trials","volume":"41 (4)","author":"Lee","year":"2010","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD013066.pub2-BIB0080|cit80","unstructured":"Lefebvre C Manheimer E Glanville J Chapter 6: Searching for studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD013066.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"i5078","DOI":"10.1136\/bmj.i5078","article-title":"Recommendations to improve adverse event reporting in clinical trial publications: a joint pharmaceutical industry\/journal editor perspective","volume":"355","author":"Lineberry","year":"2016","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD013066.pub2-BIB0082|cit82","first-page":"404","article-title":"Cytidine diphosphate choline for acute stroke: a meta-analysis","volume":"11","author":"Liu","year":"2011","journal-title":"Chinese Journal of Evidence-based Medicine"},{"issue":"2","key":"10.1002\/14651858.CD013066.pub2-BIB0083|cit83","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.MR000033.pub3","article-title":"Industry sponsorship and research outcome","author":"Lundh","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD013066.pub2-BIB0084|cit84","first-page":"61","article-title":"Functional evaluation: the Barthel index","volume":"14","author":"Mahoney","year":"1965","journal-title":"Maryland State Medical Journal"},{"issue":"2","key":"10.1002\/14651858.CD013066.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1161\/STROKEAHA.113.003798","article-title":"Acute ischemic stroke: time, penumbra, and reperfusion","volume":"45","author":"Manning","year":"2014","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD013066.pub2-BIB0086|cit86","first-page":"17\u201328","article-title":"Current knowledge on the neuroprotective and neuroregenerative properties of citicoline in acute ischemic stroke","volume":"7","author":"Martynov","year":"2015","journal-title":"Journal of Experimental Pharmacology"},{"issue":"2","key":"10.1002\/14651858.CD013066.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1213\/ANE.0000000000002741","article-title":"Significance, errors, power, and sample size: The blocking and tackling of statistics","volume":"126","author":"Mascha","year":"2018","journal-title":"Anesthesia and Analgesia"},{"key":"10.1002\/14651858.CD013066.pub2-BIB0088|cit88","unstructured":"McArthur KS Improving efficiency in stroke trials: an exploration of methods to improve the use of the modified Rankin Scale in acute stroke trials theses.gla.ac.uk\/5350 2014 1 261"},{"issue":"6","key":"10.1002\/14651858.CD013066.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.jclinepi.2011.10.016","article-title":"Published methodological quality of randomized controlled trials does not reflect the actual quality assessed in protocols","volume":"65","author":"Mhaskar","year":"2012","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD013066.pub2-BIB0090|cit90","unstructured":"NIH Stroke Scale\/Score (NIHSS) www.mdcalc.com\/nih-stroke-scale-score-nihss"},{"issue":"7","key":"10.1002\/14651858.CD013066.pub2-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.01.020","article-title":"The effects of citicoline on acute ischemic stroke: a review","volume":"23","author":"Overgaard","year":"2014","journal-title":"Journal of Stroke and Cerebrovascular Diseases"},{"issue":"6","key":"10.1002\/14651858.CD013066.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.pcad.2017.04.005","article-title":"Neuroprotection in the treatment of acute ischemic stroke","volume":"59","author":"Patel","year":"2017","journal-title":"Progress in Cardiovascular Diseases"},{"issue":"10","key":"10.1002\/14651858.CD013066.pub2-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.jclinepi.2007.11.010","article-title":"Contour-enhanced meta-analysis funnel plots help distinguish publication bias from other causes of asymmetry","volume":"61","author":"Peters","year":"2008","journal-title":"Journal of Clinical Epidemiology"},{"issue":"19","key":"10.1002\/14651858.CD013066.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1001\/archinternmed.2009.306","article-title":"Reporting of safety results in published reports of randomized controlled trials","volume":"169","author":"Pitrou","year":"2009","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD013066.pub2-BIB0095|cit95","doi-asserted-by":"crossref","DOI":"10.1093\/acref\/9780199976720.001.0001","volume-title":"A Dictionary of Epidemiology","author":"Porta","year":"2014"},{"key":"10.1002\/14651858.CD013066.pub2-BIB0096|cit96","first-page":"239","volume-title":"Handbook of Clinical Neurology","volume":"138","author":"Portegies","year":"2016"},{"issue":"4","key":"10.1002\/14651858.CD013066.pub2-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"E2","DOI":"10.3171\/2017.1.FOCUS16497","article-title":"Experimental neuroprotection in ischemic stroke: a concise review","volume":"42","author":"Rajah","year":"2017","journal-title":"Neurosurgical Focus"},{"key":"10.1002\/14651858.CD013066.pub2-BIB0098|cit98","unstructured":"Review Manager 5 (RevMan 5) Nordic Cochrane Centre, The Cochrane Collaboration 2014"},{"key":"10.1002\/14651858.CD013066.pub2-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"d549","DOI":"10.1136\/bmj.d549","article-title":"Interpretation of random effects meta-analyses","volume":"342","author":"Riley","year":"2011","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD013066.pub2-BIB0100|cit100","first-page":"164","article-title":"Down with odds ratios!","volume":"1","author":"Sackett","year":"1996","journal-title":"Evidence-based Medicine"},{"key":"10.1002\/14651858.CD013066.pub2-BIB0101|cit101","unstructured":"Saver JL Wilterdink J Choline precursors in acute and subacute human stroke: a meta-analysis Stroke 2002 33 1 353"},{"key":"10.1002\/14651858.CD013066.pub2-BIB0102|cit102","unstructured":"Sch\u00fcnemann HJ Oxman AD Vist GE Higgins JP Deeks JJ Glasziou P Chapter 12: Interpreting results and drawing conclusions. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD013066.pub2-BIB0103|cit103","unstructured":"Sch\u00fcnemann HJ Oxman AD Vist GE Higgins JP Deeks JJ Glasziou P Green S editor(s) Cochrane Handbook for Systematic Reviews of Interventions Version 510 (updated March 2011) The Cochrane Collaboration Chapter 11: Interpreting results and drawing conclusions Available from handbook.cochrane.org"},{"issue":"1","key":"10.1002\/14651858.CD013066.pub2-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0895-4356(96)00312-5","article-title":"Statistical assessment of ordinal outcomes in comparative studies","volume":"50","author":"Scott","year":"1997","journal-title":"Journal of Clinical Epidemiology"},{"issue":"8","key":"10.1002\/14651858.CD013066.pub2-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.04.010","article-title":"Citicoline for acute ischemic stroke: a systematic review and formal meta-analysis of randomized, double-blind, and placebo-controlled trials","volume":"25","author":"Secades","year":"2016","journal-title":"Journal of Stroke and Cerebrovascular Diseases"},{"issue":"3","key":"10.1002\/14651858.CD013066.pub2-BIB0106|cit106","first-page":"161","article-title":"Power and sample size when multiple endpoints are considered","volume":"6","author":"Senn","year":"2007","journal-title":"Pharmaceutical Satistics"},{"issue":"2","key":"10.1002\/14651858.CD013066.pub2-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s11596-016-1579-6","article-title":"Early application of citicoline in the treatment of acute stroke: A meta-analysis of randomized controlled trials","volume":"36","author":"Shi","year":"2016","journal-title":"Journal of Huazhong University of Science and Technology. Medical Sciences"},{"issue":"5","key":"10.1002\/14651858.CD013066.pub2-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1177\/1352458517695471","article-title":"The most frequently asked question to a statistician: the sample size","volume":"23","author":"Sormani","year":"2017","journal-title":"Multiple Sclerosis"},{"key":"10.1002\/14651858.CD013066.pub2-BIB0109|cit109","unstructured":"Standard Protocol Items: Recommendations for Interventional Trials www.spirit-statement.org\/"},{"key":"10.1002\/14651858.CD013066.pub2-BIB0110|cit110","unstructured":"StataCorp LLC Stata 14 www.stata.com"},{"key":"10.1002\/14651858.CD013066.pub2-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/9780470693926.ch18","volume-title":"Systematic Reviews in Health Care: Meta-analysis in Context","author":"Sterne","year":"2001"},{"key":"10.1002\/14651858.CD013066.pub2-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"d4002","DOI":"10.1136\/bmj.d4002","article-title":"Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials","volume":"343","author":"Sterne","year":"2011","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD013066.pub2-BIB0113|cit113","first-page":"57","article-title":"Interpreting meta-analysis according to the adequacy of sample size. An example using isoniazid chemoprophylaxis for tuberculosis in purified protein derivative negative HIV-infected individuals","volume":"2","author":"Thorlund","year":"2010","journal-title":"Clinical Epidemiology"},{"key":"10.1002\/14651858.CD013066.pub2-BIB0114|cit114","unstructured":"Thorlund K Engstr\u00f8m J Wetterslev J Brok J Imberger G Gluud C User manual for Trial Sequential Analysis (TSA) ctu.dk\/tsa\/files\/tsa_manual.pdf"},{"issue":"10","key":"10.1002\/14651858.CD013066.pub2-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"e25491","DOI":"10.1371\/journal.pone.0025491","article-title":"The number of patients and events required to limit the risk of overestimation of intervention effects in meta-analysis--a simulation study","volume":"6","author":"Thorlund","year":"2011","journal-title":"PloS One"},{"key":"10.1002\/14651858.CD013066.pub2-BIB0116|cit116","first-page":"Article 15","article-title":"Augmentation procedures for control of the generalized family-wise error rate and tail probabilities for the proportion of false positives","volume":"3","author":"Laan","year":"2004","journal-title":"Statistical Applications in Genetics and Molecular Biology"},{"issue":"5","key":"10.1002\/14651858.CD013066.pub2-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1161\/01.STR.19.5.604","article-title":"Interobserver agreement for the assessment of handicap in stroke patients","volume":"19","author":"Swieten","year":"1988","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD013066.pub2-BIB0118|cit118","first-page":"1459\u2013544","article-title":"Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980\u20132015: a systematic analysis for the Global Burden of Disease Study 2015","volume":"388","author":"Wang","year":"2016","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD013066.pub2-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"40137","DOI":"10.1038\/srep40137","article-title":"Network-based approach to identify potential targets and drugs that promote neuroprotection and neurorepair in acute ischemic stroke","volume":"7","author":"Wang","year":"2017","journal-title":"Scientific Reports"},{"issue":"7","key":"10.1002\/14651858.CD013066.pub2-BIB0120|cit120","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000213.pub3","article-title":"Thrombolysis for acute ischaemic stroke","author":"Wardlaw","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD013066.pub2-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jclinepi.2007.03.013","article-title":"Trial Sequential Analysis may establish when firm evidence is reached in cumulative meta-analysis","volume":"61","author":"Wetterslev","year":"2008","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD013066.pub2-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1471-2288-9-86","article-title":"Estimating required information size by quantifying diversity in random-effects model meta-analyses","volume":"9","author":"Wetterslev","year":"2009","journal-title":"BMC Medical Research Methodology"},{"issue":"1","key":"10.1002\/14651858.CD013066.pub2-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12874-017-0315-7","article-title":"Trial Sequential Analysis in systematic reviews with meta-analysis","volume":"17","author":"Wetterslev","year":"2017","journal-title":"BMC Medical Research Methodology"},{"key":"10.1002\/14651858.CD013066.pub2-BIB0124|cit124","first-page":"157","volume-title":"Disease Control Priorities (openknowledge.worldbank.org\/handle\/10986\/28875)","volume":"5","author":"Yan","year":"2017"},{"issue":"1","key":"10.1002\/14651858.CD013066.pub2-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1177\/1740774518812774","article-title":"Beware of on-treatment safety analyses","volume":"16","author":"Yang","year":"2019","journal-title":"Clinical Trials"},{"issue":"7","key":"10.1002\/14651858.CD013066.pub2-BIB0126|cit126","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013066","article-title":"Citicoline for treating people with acute ischemic stroke","author":"Marti-Carvajal","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T04:19:48Z","timestamp":1710994788000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD013066.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Stroke Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,8,29]]},"references-count":126,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2020,12]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd013066.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,29]]}}}